Myabetic
Myabetic is a small Santa Monica-based online retailer selling diabetes supply cases, bags, and accessories to individuals living with diabetes, founded and creatively directed by Kyrra Richards.
- Company typePrivate
- Founded-
- HeadquartersSanta Monica, United States
- Headcount1–10
- GTM typeB2C
- OfferingHardware or Manufacturing
What Myabetic does
Myabetic is a small online retailer specializing in diabetes lifestyle accessories, including supply cases, bags, and related carrying products designed for individuals managing diabetes. Founded and led by Kyrra Richards as Founder and Creative Director, the company targets the diabetes community with functional, aesthetically oriented accessories intended to organize and transport medical supplies such as glucose meters, insulin pens, and related equipment. The business operates as a direct-to-consumer e-commerce brand with a website at myabetic.com, based in Santa Monica, California, and operates with a small team of 1-10 employees.
The commercial model is a single-channel online retail store selling branded diabetes accessories. Revenue mechanics are not disclosed in the available data; pricing, gross margin, average order value, and customer acquisition costs are not specified. The company's customer base is individuals living with diabetes, served through the DTC storefront rather than B2B distribution or enterprise contracts. The bulk of the provided source data pertains to Afrezza, an inhaled insulin product by MannKind Corporation, which is not the same entity as Myabetic and does not represent Myabetic's product, technology, or business model. Consequently, the technological, financial, and partnership signals available for Myabetic are limited to its firmographic and founder profile.
Myabetic firmographics
Firmographics- Name
- Myabetic
- Website
- https://myabetic.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Myabetic is a small Santa Monica-based online retailer selling diabetes supply cases, bags, and accessories to individuals living with diabetes, founded and creatively directed by Kyrra Richards.
- Ownership category
- akta.pro rank
Myabetic industry classification
Industry- Product category
- Diabetes Management Accessories
- NAICS
- Health and Personal Care Retailers (456)
- SIC
- Retail-Catalog & Mail-Order Houses (5961)
- akta.pro primary industry
- Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers) (CRACAQAE)
Keywords
Where Myabetic is headquartered
LocationHeadquarters
- HQ city
- Santa Monica
- HQ country
- United States
- HQ region
- North America
Markets served
Myabetic business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Operations, Personnel
Revenue model
- Prescription Insulin Sales: Afrezza generates revenue through prescription-based sales of inhaled insulin. The product is dispensed through retail pharmacies and delivered to patients via prescription. Revenue is realized when patients fill their prescriptions through insurance or cash payment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Standard prescription pricing with patient assistance |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Myabetic product offering
Product offeringCore offering
Myabetic is an online retailer that sells diabetes supply cases, diabetes bags, and diabetes accessories directly to individual consumers living with diabetes. The company's products are designed to help users organize and carry everyday diabetes management supplies such as glucose meters, test strips, insulin pens, and related items. Sales are conducted through the company's own e-commerce storefront at myabetic.com.
Product overview
Afrezza is a single rapid-acting inhaled insulin product manufactured by MannKind Corporation. The product consists of insulin human inhalation powder delivered via a proprietary inhaler device. It provides ultra rapid-acting mealtime insulin coverage for diabetes patients ages 6 and older, working in conjunction with basal insulin for type 1 diabetes patients. The product's key differentiator is its needle-free, no-planning-required delivery mechanism that enables spontaneous dosing at mealtime with onset of action in approximately 12 minutes.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 97% of patients pay $35.00 or less out of pocket
- +2 more outcomes
Companies that use Myabetic
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles1 record
Myabetic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Myabetic partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- UpScriptcoreUpScript is a telemedicine platform partner that enables patients to consult with licensed healthcare providers online to determine if Afrezza is appropriate for their diabetes management. This partnership provides a direct channel for patient acquisition and prescription initiation.
- FedExminorFedEx provides shipping services for the MannKind Cares replacement inhaler program, delivering shipments within 3-5 business days.
Scale indicators1 record
Myabetic competitors and assessment
Company assessmentBroad incumbents
- Baggu: Baggu is a designer bag and accessories brand carried by major retailers. While not diabetes-specific, its scale, lower prices, and design cachet represent the kind of broader-accessory competitor that could compress Myabetic's lifestyle premium.
- Abbott Diabetes Care: Abbott Diabetes Care (FreeStyle Libre) is a major CGM manufacturer. Like Dexcom, it does not sell accessory cases itself, but its large installed base drives demand for the kind of carrying cases and overlays Myabetic produces.
- Tandem Diabetes Care: Tandem makes the t:slim X2 insulin pump and competes in the broader diabetes device ecosystem. Tandem customers are core buyers of third-party cases and accessories, situating Tandem as an adjacent ecosystem incumbent.
- Insulet (Omnipod): Insulet is a leading tubeless insulin patch pump manufacturer serving the same diabetes patient base as Myabetic. It is not an accessory maker but its Omnipod customers actively buy third-party cases and bands, making it a key ecosystem context.
- Dexcom: Dexcom is the leading continuous glucose monitor (CGM) maker; Myabetic's CGM-friendly cases, bands, and travel accessories are purchased by Dexcom users, positioning Dexcom as a complementary ecosystem incumbent.
- Medtronic Diabetes: Medtronic Diabetes is a broad incumbent in insulin pumps and CGM. Its consumer base overlaps Myabetic's target market, particularly pediatric Type 1 customers whose parents often purchase branded accessory bags.
- Vera Bradley: Vera Bradley is a broader lifestyle bag and accessories brand with size, distribution, and brand awareness Myabetic lacks. Its quilted patterned bags and organizers compete for the same women's-accessory wallet share, especially during gifting season.
Direct peers
- FRIO: FRIO makes evaporative cooling wallets and travel cases designed to keep insulin at safe temperatures, competing in the same diabetes-accessory space with a different functional angle (temperature control) but overlapping buyer.
- Medicool (Dia-Pak): Medicool produces the Dia-Pak line of diabetes supply cases, organizers, and insulin pen wallets that compete directly with Myabetic's core cases/bags category for customers carrying meters, strips, and insulin pens.
- Sugar Medical Supply: Sugar Medical Supply is a direct-to-consumer online retailer of designer diabetes supply bags, cases, and organizers. It competes head-to-head with Myabetic in the same niche of fashionable diabetes accessory cases for adults and children.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
Myabetic social profiles
Digital presenceMyabetic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Myabetic leadership team
Management profileNumber of profiles
Profiles1 record
Myabetic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Myabetic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Myabetic
What does Myabetic do?
Myabetic is an online retailer that sells diabetes supply cases, diabetes bags, and diabetes accessories directly to individual consumers living with diabetes. The company's products are designed to help users organize and carry everyday diabetes management supplies such as glucose meters, test strips, insulin pens, and related items. Sales are conducted through the company's own e-commerce storefront at myabetic.com.
Is Myabetic a public or private company?
Myabetic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Myabetic founded?
Myabetic was founded in -1. It employs 1 to 10 people.
Where is Myabetic based?
Myabetic is headquartered in Santa Monica, United States, in the North America region.
How does Myabetic make money?
One revenue line is on record: prescription Insulin Sales.
Who are Myabetic's main competitors?
Broad incumbents on record are Baggu, Abbott Diabetes Care, Tandem Diabetes Care, Insulet (Omnipod), Dexcom, Medtronic Diabetes and Vera Bradley. Direct peers are FRIO, Medicool (Dia-Pak) and Sugar Medical Supply.
Does Myabetic have an API?
No public API is recorded for Myabetic.
What industry is Myabetic in?
Myabetic's product category is Diabetes Management Accessories. Its primary akta.pro industry code is CRACAQAE, Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers). Its NAICS code is 456 and its SIC code is 5961.